{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["18\u03b1-Glycyrrhetinic acid", "EGFR-PI3K/AKT pathway", "NSCLC", "apoptosis", "network pharmacology", "survival analysis", "triterpenoid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36313358", "DateRevised": {"Year": "2022", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "12"}], "Language": ["eng"], "ELocationID": ["1018974", "10.3389/fphar.2022.1018974"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18\u03b1- glycyrrhetinic acid against non-small cell lung cancer.", "Pagination": {"StartPage": "1018974", "MedlinePgn": "1018974"}, "Abstract": {"AbstractText": ["Non-small cell lung cancer (NSCLC) is one of the most malignant types of cancer with soaring incidence rates worldwide, attributed to its heterogeneity and complex etiology. Evidently, alternative anti-cancer therapies comprising traditional medicines and natural products have gained attention for their ability to act as chemopreventive agents with minimal toxicities, either alone or in combination. Accumulating studies have substantiated the inevitability of network pharmacology studies for effectively mapping molecular targets of natural products against multifaceted diseases, including cancer. The 18\u03b1-Glycyrrhetinic acid (18\u03b1-GA), a triterpenoid found in licorice plants, has shown promising medicinal properties, although, its mechanism of action against NSCLC yet remains elusive. The present study was conducted to explore the anti- NSCLC potential of 18\u03b1-GA, employing integrative network pharmacology, molecular docking, and experimental research. Initially, network analysis revealed 181 common targets of 18\u03b1-GA in NSCLC as shown in the \"compound-target- disease\" network employing <i>Cytoscape 3.8.2</i>. Further analyses identified EGFR, AKT1, PI3KR1, MAPK1, IGF1, and SRC as the most crucial hub targets of 18\u03b1-GA against NSCLC. Moreover, molecular docking simulations and functional enrichment analyses indicated the involvement of multiple signaling pathways in suppressing NSCLC. Subsequent <i>in-vitro</i> studies verified the antiproliferative effect of 18\u03b1-GA on two NSCLC cancer cell lines, H1299 and A549. Mechanistically, 18\u03b1-GA arrested cell cycle at the G1 phase, induced apoptosis, decreased migratory potential, and protein expression levels of EGFR-PI3K/AKT, as examined by flow cytometry, morphological assessment, RT-PCR, and western blot. In conclusion, this study delineates the therapeutic potential and underlying mechanism(s) of 18\u03b1-GA as a putative novel drug against NSCLC. However, further studies are warranted to elucidate the complete molecular mechanism(s) using animal models of NSCLC."], "CopyrightInformation": "Copyright \u00a9 2022 Irshad, Raj, Gabr, Manzoor and Husain."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology and Oncology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Irshad", "ForeName": "Rasha", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Mycology Lab, Department of Biosciences, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Raj", "ForeName": "Nafis", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al- Kharj, Saudi Arabia."}], "LastName": "Gabr", "ForeName": "Gamal A", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Mycology Lab, Department of Biosciences, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Manzoor", "ForeName": "Nikhat", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology and Oncology Lab, Department of Biotechnology, Jamia Millia Islamia, New Delhi, India."}], "LastName": "Husain", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alam S., Mohammad T., Padder R. A., Hassan M. I., Husain M. (2022). Thymoquinone and quercetin induce enhanced apoptosis in non-small cell lung cancer in combination through the Bax/Bcl2 cascade. J. Cell Biochem. 123, 259\u2013274. 10.1002/jcb.30162", "ArticleIdList": ["10.1002/jcb.30162", "34636440"]}, {"Citation": "Alexander M., Kim S. Y., Cheng H. (2020). Update 2020: Management of non-small cell lung cancer. Lung 198, 897\u2013907. 10.1007/s00408-020-00407-5", "ArticleIdList": ["10.1007/s00408-020-00407-5", "PMC7656891", "33175991"]}, {"Citation": "Ali R., Tabrez S., Akand S. K., Rahman F., Husein A., Arish M., et al. fnm (2021). Sesamol induces apoptosis-like cell death in leishmania donovani. Front. Cell Infect. Microbiol. 11. 749420. 10.3389/fcimb.2021.749420", "ArticleIdList": ["10.3389/fcimb.2021.749420", "PMC8581470", "34778106"]}, {"Citation": "Bade B. C., dela Cruz C. S. (2020). Lung cancer 2020: Epidemiology, etiology, and prevention. Clin. Chest Med. 41, 1\u201324. 10.1016/j.ccm.2019.10.001", "ArticleIdList": ["10.1016/j.ccm.2019.10.001", "32008623"]}, {"Citation": "Bhat F. A., Sharmila G., Balakrishnan S., Arunkumar R., Elumalai P., Suganya S., et al. (2014). Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J. Nutr. Biochem. 25, 1132\u20131139. 10.1016/j.jnutbio.2014.06.008", "ArticleIdList": ["10.1016/j.jnutbio.2014.06.008", "25150162"]}, {"Citation": "Chandran U., Mehendale N., Patil S., Chaguturu R., Patwardhan B. (2017). \u201cChapter 5 - network pharmacology,\u201d in Innovative approaches in drug discovery, 1."}, {"Citation": "Chang F., Lee J. T., Navolanic P. M., Steelman L. S., Shelton J. G., Blalock W. L., et al. (2003). Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy. Leukemia 17, 590\u2013603. 10.1038/sj.leu.2402824", "ArticleIdList": ["10.1038/sj.leu.2402824", "12646949"]}, {"Citation": "Charmsaz S., Prencipe M., Kiely M., Pidgeon G. P., Collins D. M. (2018). Innovative technologies changing cancer treatment. Cancers (Basel) 10, 208. 10.3390/cancers10060208", "ArticleIdList": ["10.3390/cancers10060208", "PMC6025540", "29921753"]}, {"Citation": "Chen R., Manochakian R., James L., Azzouqa A. G., Shi H., Zhang Y., et al. (2020). Emerging therapeutic agents for advanced non-small cell lung cancer. J. Hematol. Oncol. 13, 138. 10.1186/s13045-020-00881-7", "ArticleIdList": ["10.1186/s13045-020-00881-7", "PMC7245927", "32448366"]}, {"Citation": "Creed S., McKenzie M. (2019). \u201cMeasurement of mitochondrial membrane potential with the fluorescent dye tetramethylrhodamine methyl ester (TMRM),\u201d in Methods in molecular biology, 1. 10.1007/978-1-4939-9027-6_5", "ArticleIdList": ["10.1007/978-1-4939-9027-6_5", "30725451"]}, {"Citation": "da Cunha Santos G., Shepherd F. A., Tsao M. S. (2011). EGFR mutations and lung cancer. Annu. Rev. Pathology Mech. Dis. 6, 49\u201369. 10.1146/annurev-pathol-011110-130206", "ArticleIdList": ["10.1146/annurev-pathol-011110-130206", "20887192"]}, {"Citation": "Daina A., Michielin O., Zoete V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. 10.1038/srep42717", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Daina A., Michielin O., Zoete V. (2019). SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364. 10.1093/nar/gkz382", "ArticleIdList": ["10.1093/nar/gkz382", "PMC6602486", "31106366"]}, {"Citation": "Duan H., Qu L., Shou C. (2014). Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration. Cancer Cell Int. 14, 135. 10.1186/s12935-014-0135-3", "ArticleIdList": ["10.1186/s12935-014-0135-3", "PMC4262230", "25505372"]}, {"Citation": "Fang J., Cai C., Wang Q., Lin P., Zhao Z., Cheng F. (2017). Systems pharmacology-based discovery of natural products for precision oncology through targeting cancer mutated genes. CPT Pharmacometrics Syst. Pharmacol. 6, 177\u2013187. 10.1002/psp4.12172", "ArticleIdList": ["10.1002/psp4.12172", "PMC5356618", "28294568"]}, {"Citation": "Ghante M. H., Jamkhande P. G. (2019). Role of pentacyclic triterpenoids in chemoprevention and anticancer treatment: An overview on targets and underling mechanisms. J. Pharmacopuncture 22, 55\u201367. 10.3831/KPI.201.22.007", "ArticleIdList": ["10.3831/KPI.201.22.007", "PMC6645347", "31338244"]}, {"Citation": "Gridelli C., Rossi A., Carbone D. P., Guarize J., Karachaliou N., Mok T., et al. (2015). Non-small-cell lung cancer. Nat. Rev. Dis. Prim. 1, 1. 10.1038/nrdp.2015.9", "ArticleIdList": ["10.1038/nrdp.2015.9", "27188576"]}, {"Citation": "Ha Y. M., Cheung A. P., Lim P. (1991). Chiral separation of glycyrrhetinic acid by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 9, 805\u2013809. 10.1016/0731-7085(91)80005-t", "ArticleIdList": ["10.1016/0731-7085(91)80005-t", "1822198"]}, {"Citation": "Huang D. W., Sherman B. T., Tan Q., Kir J., Liu D., Bryant D., et al. (2007). DAVID Bioinformatics Resources: Expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35, W169\u2013W175. 10.1093/nar/gkm415", "ArticleIdList": ["10.1093/nar/gkm415", "PMC1933169", "17576678"]}, {"Citation": "Huber M. A., Kraut N., Beug H. (2005). Molecular requirements for epithelial\u2013mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548\u2013558. 10.1016/J.CEB.2005.08.001", "ArticleIdList": ["10.1016/J.CEB.2005.08.001", "16098727"]}, {"Citation": "Irshad R., Husain M. (2021). Natural products in the reprogramming of cancer epigenetics. Toxicol. Appl. Pharmacol. 417, 115467. 10.1016/j.taap.2021.115467", "ArticleIdList": ["10.1016/j.taap.2021.115467", "33631231"]}, {"Citation": "Jeon Y. J., Cho J. H., Lee S. Y., Choi Y. H., Park H., Jung S., et al. (2016). Esculetin induces apoptosis through EGFR/PI3K/Akt signaling pathway and nucleophosmin relocalization. J. Cell Biochem. 117, 1210\u20131221. 10.1002/jcb.25404", "ArticleIdList": ["10.1002/jcb.25404", "26447856"]}, {"Citation": "Kasibhatla S., Amarante-Mendes G. P., Finucane D., Brunner T., Bossy-Wetzel E., Green D. R. (2006). Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. Cold Spring Harb. Protoc. 2006, 1. 10.1101/pdb.prot4493", "ArticleIdList": ["10.1101/pdb.prot4493", "22485874"]}, {"Citation": "Kibble M., Saarinen N., Tang J., Wennerberg K., M\u00e4kel\u00e4 S., Aittokallio T. (2015). Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat. Prod. Rep. 32, 1249\u20131266. 10.1039/c5np00005j", "ArticleIdList": ["10.1039/c5np00005j", "26030402"]}, {"Citation": "L\u00e1nczky A., Gy\u0151rffy B. (2021). Web-based survival analysis tool tailored for medical research (KMplot): Development and implementation. J. Med. Internet Res. 23, e27633. 10.2196/27633", "ArticleIdList": ["10.2196/27633", "PMC8367126", "34309564"]}, {"Citation": "Li J., Tang F., Li R., Chen Z., Lee S. M. Y., Fu C., et al. (2020). Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo . J. Nutr. Biochem. 77, 108268. 10.1016/j.jnutbio.2019.108268", "ArticleIdList": ["10.1016/j.jnutbio.2019.108268", "31830590"]}, {"Citation": "Li S., Zhang B. (2013). Traditional Chinese medicine network pharmacology: Theory, methodology and application. Chin. J. Nat. Med. 11, 110\u2013120. 10.1016/S1875-5364(13)60037-0", "ArticleIdList": ["10.1016/S1875-5364(13)60037-0", "23787177"]}, {"Citation": "Markov A. v., Zenkova M. A., Logashenko E. B. (2017). Modulation of tumour-related signaling pathways by natural pentacyclic triterpenoids and their semisynthetic derivatives. Curr. Med. Chem. 24, 1277\u20131320. 10.2174/0929867324666170112115313", "ArticleIdList": ["10.2174/0929867324666170112115313", "28078994"]}, {"Citation": "Mohammad T., Mathur Y., Hassan M. I. (2021). InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief. Bioinform 22, bbaa279. 10.1093/bib/bbaa279", "ArticleIdList": ["10.1093/bib/bbaa279", "33105480"]}, {"Citation": "Mustafa S., Pawar J. S., Ghosh I. (2021). Fucoidan induces ROS-dependent epigenetic modulation in cervical cancer HeLa cell. Int. J. Biol. Macromol. 181, 180\u2013192. 10.1016/j.ijbiomac.2021.03.110", "ArticleIdList": ["10.1016/j.ijbiomac.2021.03.110", "33771548"]}, {"Citation": "Nicholson K., Anderson N. (2002). Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 14, 381\u2013395. 10.1016/S0898-6568(01)00271-6", "ArticleIdList": ["10.1016/S0898-6568(01)00271-6", "11882383"]}, {"Citation": "Padder R. A., Bhat Z. I., Ahmad Z., Singh N., Husain M. (2021). DRP1 promotes brafv600e-driven tumor progression and metabolic reprogramming in colorectal cancer. Front. Oncol. 10, 592130. 10.3389/fonc.2020.592130", "ArticleIdList": ["10.3389/fonc.2020.592130", "PMC7961078", "33738242"]}, {"Citation": "Perlman H., Zhang X., Chen M. W., Walsh K., Buttyan R. (1999). An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ. 6, 48\u201354. 10.1038/sj.cdd.4400453", "ArticleIdList": ["10.1038/sj.cdd.4400453", "10200547"]}, {"Citation": "Pilling A. B., Hwang C. (2019). Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide. Prostate 79, 1347\u20131359. 10.1002/pros.23843", "ArticleIdList": ["10.1002/pros.23843", "PMC6617752", "31228231"]}, {"Citation": "Pirzadeh S., Fakhari S., Jalili A., Mirzai S., Ghaderi B., Haghshenas V. (2014). Glycyrrhetinic acid induces apoptosis in leukemic HL60 cells through upregulating of CD95/CD178. Int. J. Mol. Cell. Med. 3 (4), 272\u2013278.", "ArticleIdList": ["PMC4293615", "25635254"]}, {"Citation": "Raghunandhakumar S., Paramasivam A., Senthilraja S., Naveenkumar C., Asokkumar S., Binuclara J., et al. (2013). Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma. Toxicol. Lett. 223, 60\u201372. 10.1016/J.TOXLET.2013.08.018", "ArticleIdList": ["10.1016/J.TOXLET.2013.08.018", "24012840"]}, {"Citation": "Rahman M. A., Bishayee K., Habib K., Sadra A., Huh S. O. (2016). 18\u03b1-Glycyrrhetinic acid lethality for neuroblastoma cells via de-regulating the Beclin-1/Bcl-2 complex and inducing apoptosis. Biochem. Pharmacol. 117, 97\u2013112. 10.1016/j.bcp.2016.08.006", "ArticleIdList": ["10.1016/j.bcp.2016.08.006", "27520483"]}, {"Citation": "Salakou S., Kardamakis D., Tsamandas A. C., Zolota V., Apostolakis E., Tzelepi V., et al. (2007). \u201cIncreased bax/bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with Myasthenia gravis,\u201d in Vivo (brooklyn), 21.", "ArticleIdList": ["17354625"]}, {"Citation": "Salehi M., Movahedpour A., Tayarani A., Shabaninejad Z., Pourhanifeh M. H., Mortezapour E., et al. (2020). Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma. Phytotherapy Res. 34, 2557\u20132576. 10.1002/ptr.6704", "ArticleIdList": ["10.1002/ptr.6704", "32307773"]}, {"Citation": "Salvador J. A. R., Leal A. S., Valdeira A. S., Gon\u00e7alves B. M. F., Alho D. P. S., Figueiredo S. A. C., et al. (2017). Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment. Eur. J. Med. Chem. 142, 95\u2013130. 10.1016/j.ejmech.2017.07.013", "ArticleIdList": ["10.1016/j.ejmech.2017.07.013", "28754470"]}, {"Citation": "Sathya S., Sudhagar S., Sarathkumar B., Lakshmi B. S. (2014). EGFR inhibition by pentacyclic triterpenes exhibit cell cycle and growth arrest in breast cancer cells. Life Sci. 95, 53\u201362. 10.1016/j.lfs.2013.11.019", "ArticleIdList": ["10.1016/j.lfs.2013.11.019", "24333132"]}, {"Citation": "Seshacharyulu P., Ponnusamy M. P., Haridas D., Jain M., Ganti A. K., Batra S. K. (2012). Targeting the EGFR signaling pathway in cancer therapy. Expert Opin. Ther. Targets 16, 15\u201331. 10.1517/14728222.2011.648617", "ArticleIdList": ["10.1517/14728222.2011.648617", "PMC3291787", "22239438"]}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N. S., Wang J. T., Ramage D., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504. 10.1101/gr.1239303", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Shetty A. v., Thirugnanam S., Dakshinamoorthy G., Samykutty A., Zheng G., Chen A., et al. (2011). 18\u03b1-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes. Int. J. Oncol. 39, 635\u2013640. 10.3892/ijo.2011.1061", "ArticleIdList": ["10.3892/ijo.2011.1061", "21637916"]}, {"Citation": "Sun H., Wang F., Huang Y., Wang J., Zhang L., Shen Y., et al. (2022). Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma. J. Cancer 13, 951\u2013964. 10.7150/jca.52778", "ArticleIdList": ["10.7150/jca.52778", "PMC8824901", "35154461"]}, {"Citation": "Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. 10.3322/caac.21660", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Szklarczyk D., Gable A. L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., et al. (2019). STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, 1. 10.1093/nar/gky1131", "ArticleIdList": ["10.1093/nar/gky1131", "PMC6323986", "30476243"]}, {"Citation": "Takeuchi R., Hiratsuka K., Arikawa K., Ono M., Komiya M., Akimoto Y., et al. (2016). Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18\u03b1-glycyrrhetinic acid inhibits human gingival fibroblast growth. Br. J. Pharmacol. 173, 913\u2013924. 10.1111/bph.13410", "ArticleIdList": ["10.1111/bph.13410", "PMC4761096", "26676684"]}, {"Citation": "Tian W., Chen C., Lei X., Zhao J., Liang J. (2018). CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Res. 46, W363\u2013W367. 10.1093/nar/gky473", "ArticleIdList": ["10.1093/nar/gky473", "PMC6031066", "29860391"]}, {"Citation": "Tiboni M., Benedetti S., Skouras A., Curzi G., Perinelli D. R., Palmieri G. F., et al. (2020). 3D-printed microfluidic chip for the preparation of glycyrrhetinic acid-loaded ethanolic liposomes. Int. J. Pharm. 584, 119436. 10.1016/j.ijpharm.2020.119436", "ArticleIdList": ["10.1016/j.ijpharm.2020.119436", "32445905"]}, {"Citation": "Wang X., Shen Y., Wang S., Li S., Zhang W., Liu X., et al. (2017). PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45, W356\u2013W360. 10.1093/nar/gkx374", "ArticleIdList": ["10.1093/nar/gkx374", "PMC5793840", "28472422"]}, {"Citation": "Yang Y., Li N., Wang T.-M., Di L. (2021). Natural products with activity against lung cancer: A review focusing on the tumor microenvironment. Int. J. Mol. Sci. 22, 10827. 10.3390/ijms221910827", "ArticleIdList": ["10.3390/ijms221910827", "PMC8509218", "34639167"]}, {"Citation": "Zhu L., Han M. B., Gao Y., Wang H., Dai L., Wen Y., et al. (2015). Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes. Mol. Med. Rep. 12, 1151\u20131156. 10.3892/mmr.2015.3450", "ArticleIdList": ["10.3892/mmr.2015.3450", "25760477"]}, {"Citation": "Zong L., Qu Y., Xu M., Dong Y., Lu L. (2012). 18\u03b1-glycyrrhetinic acid down-regulates expression of type I and III collagen via TGF-\u03921/Smad signaling pathway in human and rat hepatic stellate cells. Int. J. Med. Sci. 9, 370\u2013379. 10.7150/ijms.4395", "ArticleIdList": ["10.7150/ijms.4395", "PMC3399217", "22811611"]}, {"Citation": "Zong L., Qu Y., Xu M. Y., Dong Y. W., Lu L. G. (2013). 18\u03b1-glycyrrhetinic acid extracted from Glycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell line. J. Dig. Dis. 14, 328\u2013336. 10.1111/1751-2980.12041", "ArticleIdList": ["10.1111/1751-2980.12041", "23362936"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "14"}, {"Year": "2022", "Month": "9", "Day": "28"}, {"Year": "2022", "Month": "10", "Day": "31", "Hour": "4", "Minute": "56"}, {"Year": "2022", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["36313358", "PMC9596789", "10.3389/fphar.2022.1018974", "1018974"]}}], "PubmedBookArticle": []}